Product Code: IRD-25
From £445.00
Registration closed: 28/02/2025
Applicable to all labs undertaking molecular genetic testing for syndromic and non-syndromic IRD.
Any molecular test
English
DNA (in TE Buffer)
No
The scheme is designed to assess the entire diagnostic pipeline of a laboratory, including sample receipt and processing, analytical processing (genotyping), and reporting (biological and clinical interpretation of the test result) in the context of a clinical referral, as well as reporting clarity, content and clerical accuracy.
Four mock clinical cases with matching samples will be provided- a minimum of two NGS panel testing (one of which may be a "virtual" case), one case involving a variant in a gene related to an approved/in trial therapy, and one optional case for RPGR ORF15testing. Laboratories that do not perform RPGR ORF15 testing are not required to participate in the optional case.
Approximately 1.0-2.0µg DNA per sample is provided. Complete information will be available in scheme instructions.
Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.
Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
No restrictions on number of participants. Open to laboratories from ALL countries (note: some restrictions may apply*)
*Sanctions, delivery network exceptions, restrictions on importation etc.
added wishlist!
View Wishlist
View Wishlist
Express your interest in ''.